You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid, Chronic-Phase

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Amman, Jordan
  • +4 more
Jan 17, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

"Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

Not yet recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Sohag, Egypt
      Sohag University Hospital
    Sep 14, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • +2 more
    • Duarte, California
    • +1 more
    Mar 14, 2023

    Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

    Recruiting
    • Chronic Myeloid Leukemia in Chronic Phase
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022

    Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Recruiting
    • Acute Bilineal Leukemia
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 24, 2023

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Aug 17, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    Aug 24, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Orca-Q
    • Gainesville, Florida
      University of Florida
    Aug 26, 2022

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • DSP107
    • +2 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center, Department of
    Nov 13, 2022

    Generic Imatinib Compared to Glivec® in Real-Life Management of

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Cairo, Egypt
    • +1 more
    Mar 16, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Baltimore, Boston, Columbus (Enasidenib)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Chronic Myelomonocytic Leukemia
    • Baltimore, Maryland
    • +3 more
    Aug 8, 2022

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023